title: A new predictive molecular marker for cetuximab benefit in rectal cancer?
authors: Affiliations of authors: Department of Internal Medicine, University of Florida College of Medicine, Gainesville, Florida (TJG); Department of Oncology, Mayo Clinic College of Medicine Rochester, Minnesota (MJO).
authors: Thomas J
authors: TJ
authors: George
authors: Affiliations of authors: Department of Internal Medicine, University of Florida College of Medicine, Gainesville, Florida (TJG); Department of Oncology, Mayo Clinic College of Medicine Rochester, Minnesota (MJO). michael.oconnell@nsabp.org.
authors: Michael J
authors: MJ
authors: O'Connell
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000068818:Cetuximab; D005260:Female; D006801:Humans; D008297:Male; D009154:Mutation; D020360:Neoadjuvant Therapy / Q000379:methods*; D012004:Rectal Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D016159:Tumor Suppressor Protein p53 / Q000235:genetics*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C495901:TP53 protein, human; D016159:Tumor Suppressor Protein p53; D000068818:Cetuximab